LGVN: Using Cellular Technology to Ease Major Medical Issues
By Brad Sorensen, CFA
NASDAQ:LGVN
READ THE FULL LGVN RESEARCH REPORT
QNRX: Laying the Groundwork to Launch Multiple Treatments for Rare & Orphan Diseases
By M. Marin
NASDAQ:QNRX
READ THE FULL QNRX RESEARCH REPORT
DRIO: 2022 Outlook, Physimax Acquisition
By John Vandermosten, CFA
NASDAQ:DRIO
READ THE FULL DRIO RESEARCH REPORT
RCRT: Preannounces Q4 Revenues of $8.8 Million up 275%
By Lisa Thompson
NASDAQ:RCRT
READ THE FULL RCRT RESEARCH REPORT
ECOR: New Distribution Agreements Complement E-Commerce Initiative
By John Vandermosten, CFA
NASDAQ:ECOR
READ THE FULL ECOR RESEARCH REPORT
Passwords are increasingly complex, but password creation and management does not have to be
OTC:AVASF | NASDAQ:GOOG | NASDAQ:AAPL | NASDAQ:MSFT
You enter your password: Password
SNGX: Multiple Milestones Ahead in 2022…
By David Bautz, PhD
NASDAQ:SNGX
READ THE FULL SNGX RESEARCH REPORT
EMMA: Easing Suffering from Sickle Cell Disease
By Brad Sorensen, CFA
OTC:EMMA
READ THE FULL EMMA RESEARCH REPORT
SYTA: Update for Public Offering Deal Dilution Impact to Fund Topline Growth & Working Capital
By T. Moore, CFA
NASDAQ:SYTA
READ THE FULL SYTA RESEARCH REPORT